Electrocardiographic Left Ventricular Mass Trajectories and the Effects of Treatment in Patients at Different Stages of Hypertension

<b>Background:</b> The comparison of left ventricular mass (LVM) at different BP levels and the effects of antihypertensive drug treatment on LVM are unknown. <b>Objective:</b> To compare the LVM of individuals with prehypertension and Stage 1 hypertension and assess the effects of treatment on LVM at these stages of hypertension. <b>Methods:</b> We estimated LVM in the PREVER-Prevention trial using Sokolow-Lyon and Cornell voltage and voltage-duration products before and after randomization to 18 months of treatment with low doses of chlorthalidone and amiloride or placebo in adults with JNC 7 "prehypertension" (systolic BP [SBP] of 120-139 mm Hg and diastolic BP [DBP] of 80-89 mm Hg). Similarly, in the PREVER-Treatment trial, we assessed these indices before and after randomization to 18 months of treatment with the chlorthalidone/amiloride combination or losartan in adults with JNC 7 "stage 1" hypertension (140-159 mm Hg or DBP of 90-99 mm Hg). <b>Results:</b> At baseline, the participants in the stage I hypertension trial exhibited higher mean LVM indices than those in the prehypertension trial. In the PREVER-Prevention trial, those randomized to the chlorthalidone/amiloride combination experienced a significant reduction in Sokolow-Lyon LVM indices compared to placebo (<i>p</i> = 0.02). In the PREVER-Treatment trial, those randomized to the chlorthalidone/amiloride combination or losartan experienced a similar reduction in electrocardiographic LVM during the 18 months of treatment (<i>p</i> < 0.01). <b>Conclusions:</b> The institution of low-dose antihypertensive drug therapy in prehypertension and treatment of patients with stage 1 hypertension has the potential to interrupt the progress of hypertensive cardiomyopathy.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2025-03-28
DOI
https://doi.org/10.3390/jcm14072313
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Electrocardiographic Left Ventricular Mass Trajectories and the Effects of Treatment in Patients at Different Stages of Hypertension

Paulo César Brandão Veiga Jardim, Luiz Aparecido Bortolotto, Rosane Paixão Schlatter, Andréa Araújo Brandão et al.
Journal of Clinical Medicine
Blood Pressure and Hypertension Studies
article

Electrocardiographic Left Ventricular Mass Trajectories and the Effects of Treatment in Patients at Different Stages of Hypertension

Paulo César Brandão Veiga Jardim, Luiz Aparecido Bortolotto, Rosane Paixão Schlatter, Andréa Araújo Brandão, Flávio Danni Fuchs, Marcos Roberto de-Sousa, Otávio Berwanger, André Avelino Steffens, João Guilherme Bezerra Alves, Leila Beltrami Moreira, Ana Tavares, Ricardo Pereira e Silva, Fernando Nobre, Paul K. Whelton, José Albuquerque de Figueiredo Neto, Carlos Eduardo Poli‐de‐Figueiredo, Felipe Costa Fuchs, Sandra Cristina Pereira Costa Fuchs, Evandro José Cesarino, José Fernando Vilela-Martin, Luíz Cesar Nazário Scala, Dário Celestino Sobral Filho, Antônio Cláudio Lucas da Nóbrega, Iran Castro, Roberto Silva Franco, Miguel Gus, Marco M. Gomes, Leonardo Krause Valter, Beatriz Padoin Camilo
article en

Abstract

<b>Background:</b> The comparison of left ventricular mass (LVM) at different BP levels and the effects of antihypertensive drug treatment on LVM are unknown. <b>Objective:</b> To compare the LVM of individuals with prehypertension and Stage 1 hypertension and assess the effects of treatment on LVM at these stages of hypertension. <b>Methods:</b> We estimated LVM in the PREVER-Prevention trial using Sokolow-Lyon and Cornell voltage and voltage-duration products before and after randomization to 18 months of treatment with low doses of chlorthalidone and amiloride or placebo in adults with JNC 7 "prehypertension" (systolic BP [SBP] of 120-139 mm Hg and diastolic BP [DBP] of 80-89 mm Hg). Similarly, in the PREVER-Treatment trial, we assessed these indices before and after randomization to 18 months of treatment with the chlorthalidone/amiloride combination or losartan in adults with JNC 7 "stage 1" hypertension (140-159 mm Hg or DBP of 90-99 mm Hg). <b>Results:</b> At baseline, the participants in the stage I hypertension trial exhibited higher mean LVM indices than those in the prehypertension trial. In the PREVER-Prevention trial, those randomized to the chlorthalidone/amiloride combination experienced a significant reduction in Sokolow-Lyon LVM indices compared to placebo (<i>p</i> = 0.02). In the PREVER-Treatment trial, those randomized to the chlorthalidone/amiloride combination or losartan experienced a similar reduction in electrocardiographic LVM during the 18 months of treatment (<i>p</i> < 0.01). <b>Conclusions:</b> The institution of low-dose antihypertensive drug therapy in prehypertension and treatment of patients with stage 1 hypertension has the potential to interrupt the progress of hypertensive cardiomyopathy.

Journal of Clinical MedicineVol. 14(7)
Tulane University (US), Universidade de Ribeirão Preto (BR), Faculdade de Medicina de São José do Rio Preto (BR), Universidade Federal de Pelotas (BR), Universidade Federal do Ceará (BR), Universidade Federal de Mato Grosso (BR), Universidade do Estado do Rio de Janeiro (BR), Hospital de Clínicas de Porto Alegre (BR), Hospital Universitário Walter Cantídio (BR), Instituto de Medicina Integral Professor Fernando Figueira (BR), Fundação Universitária de Cardiologia (BR), Medecell (Brazil) (BR), Hospital Universitário da Universidade Federal do Maranhão (BR), Hospital das Clínicas da Universidade Federal de Minas Gerais (BR), Hospital Universitário Antônio Pedro (BR), Hospital São Lucas da PUCRS (BR), Hospital do Coração (BR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), JP Group (Brazil) (BR), Imperial College London (GB), Universidade Federal de Goiás (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Openalex Percentile: Top 91%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.